SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC14D9C - Written communication relating to third party tender offer:
SEC Accession No. 0001104659-24-065344
Filing Date
2024-05-28
Accepted
2024-05-28 08:09:18
Documents
10

Document Format Files

Seq Description Document Type Size
1 SC14D9C tm2415658d1_sc14d9c.htm SC14D9C 26231
2 EXHIBIT 99.1 tm2415658d1_ex99-1.htm EX-99.1 58260
3 EXHIBIT 99.2 tm2415658d1_ex99-2.htm EX-99.2 5635
4 EXHIBIT 99.3 tm2415658d1_ex99-3.htm EX-99.3 4409
5 EXHIBIT 99.4 tm2415658d1_ex99-4.htm EX-99.4 6926
6 GRAPHIC tm2415658d1_ex99-4img01.jpg GRAPHIC 42470
7 GRAPHIC tm2415658d1_ex99-4img02.jpg GRAPHIC 224802
8 GRAPHIC tm2415658d1_ex99-4img03.jpg GRAPHIC 162328
9 GRAPHIC tm2415658d1_ex99-4img04.jpg GRAPHIC 133047
10 GRAPHIC tm2415658d1_ex99-4img05.jpg GRAPHIC 135888
  Complete submission text file 0001104659-24-065344.txt   1061067
Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Filed by) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC14D9C
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Subject) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: SC14D9C | Act: 34 | File No.: 005-91523 | Film No.: 24986335
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)